Eden Research (LON:EDEN) Trading Down 3.3% – What’s Next?

Eden Research plc (LON:EDEN) shares dropped 3.3% during mid-day trading on Friday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares changed hands during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a market cap of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The firm has a 50 day moving average price of GBX 3.88 and a 200-day moving average price of GBX 3.95. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80.

Insider Transactions at Eden Research

In other Eden Research news, insider Alexander John Abrey bought 540,540 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek bought 256,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). 14.02% of the stock is currently owned by corporate insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.